51-30-9, 949-36-0 Isoprenaline HCl AKSci J10156
 
 
Loading Please Wait...
  J10156    AKSci Reference Standard
Isoprenaline HCl, >98% (HPLC), powder
 
1-(3',4'-Dihydroxyphenyl)-2-isopropylaminoethanol hydrochloride
N-Isopropyl-DL-noradrenaline hydrochloride
Isuprel
more..
IDENTITY
CAS Number:51-30-9, 949-36-0
MDL Number:MFCD00012603
MF:C11H18ClNO3
MW:247.72
EINECS:200-089-8
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:>98% (HPLC), powder
Physical Form (at 20°C):Solid
Melting Point:177-182°C
Long-Term Storage:Store long-term in a cool, dry place
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:H2O: 1g/3mL; EtOH (95%): 1g/50mL
Application(s):beta-adrenoceptor agonist
Form:HCl salt

REVIEW
 A non-selective beta-adrenergic agonist which was commonly used to treat asthma before the more widespread use of albuterol, which has more selective effects on the airways.

REFERENCES
[1]Soriano-Ursúa MA, McNaught-Flores DA, Nieto-Alamilla G, Segura-Cabrera A, Correa-Basurto J, Arias-Montaño JA, Trujillo-Ferrara JG (2012). Cell-based and in-silico studies on the high intrinsic activity of two boron-containing salbutamol derivatives at the human beta-2-adrenoceptor. Bioorg Med Chem. 20(2):933-41. PMID 22182578.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501

Current as of February 7, 2023

AKSci Reference Standards are high-purity, low-impurity compounds suitable for use as standards.


Download SDS Request COA

⚠️
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.


CATEGORIES
 APIs and Bioactives > Adrenergic Agonists


PubChem